133 related articles for article (PubMed ID: 10780323)
1. A functional assay suggests that heterodimers exist in two C-terminal gamma-chain dysfibrinogens: Matsumoto I and Vlissingen/Frankfurt IV.
Hogan KA; Lord ST; Okumura N; Terasawa F; Galanakis DK; Scharrer I; Gorkun OV
Thromb Haemost; 2000 Apr; 83(4):592-7. PubMed ID: 10780323
[TBL] [Abstract][Full Text] [Related]
2. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
Terasawa F; Kani S; Hongo M; Okumura N
Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
[TBL] [Abstract][Full Text] [Related]
3. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
[TBL] [Abstract][Full Text] [Related]
4. [Functional analysis of heterozygous plasma dysfibrinogens derived from two families of gammaArg275Cys and three families of gammaArg275His, and haplotype analysis for these families].
Kamijyo Y; Hirota-Kawadobora M; Fujihara N; Wakabayashi S; Matsuda K; Yamauchi K; Terasawa F; Okumura N; Honda T
Rinsho Byori; 2009 Jul; 57(7):651-8. PubMed ID: 19708534
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
Terasawa F; Okumura N; Higuchi Y; Ishikawa S; Tozuka M; Ishida F; Kitano K; Katsuyama T
Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.
Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968
[TBL] [Abstract][Full Text] [Related]
7. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene.
Iida H; Ishii E; Nakahara M; Urata M; Wakiyama M; Kurihara M; Watanabe K; Kai T; Ihara K; Kinoshita S; Hamasaki N
Thromb Haemost; 2000 Jul; 84(1):49-53. PubMed ID: 10928469
[TBL] [Abstract][Full Text] [Related]
8. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA).
Marchi R; Carvajal Z; Meyer M; Soria J; Ruiz-Saez A; Arocha-Piñango CL; Weisel JW
Thromb Res; 2006; 118(5):637-50. PubMed ID: 16406498
[TBL] [Abstract][Full Text] [Related]
10. Novel fibrinogen mutation (gamma 313 Ser-->Asn) associated with hypofibrinogenemia in two unrelated families.
Meyer M; Bergmann F; Brennan SO
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):63-7. PubMed ID: 16607083
[TBL] [Abstract][Full Text] [Related]
11. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
[TBL] [Abstract][Full Text] [Related]
12. Recombinant fibrinogen Vlissingen/Frankfurt IV. The deletion of residues 319 and 320 from the gamma chain of firbinogen alters calcium binding, fibrin polymerization, cross-linking, and platelet aggregation.
Hogan KA; Gorkun OV; Lounes KC; Coates AI; Weisel JW; Hantgan RR; Lord ST
J Biol Chem; 2000 Jun; 275(23):17778-85. PubMed ID: 10748039
[TBL] [Abstract][Full Text] [Related]
13. Recombinant variant fibrinogens substituted at residues gamma326Cys and gamma339Cys demonstrated markedly impaired secretion of assembled fibrinogen.
Haneishi A; Terasawa F; Fujihara N; Yamauchi K; Okumura N; Katsuyama T
Thromb Res; 2009 Jul; 124(3):368-72. PubMed ID: 19419756
[TBL] [Abstract][Full Text] [Related]
14. Evidence that heterodimers exist in the fibrinogen Matsumoto II (gamma308N-->K) proband and participate in fibrin fiber formation.
Okumura N; Terasawa F; Fujita K; Fujihara N; Tozuka M; Koh CS
Thromb Res; 2002 Aug; 107(3-4):157-62. PubMed ID: 12431483
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J
Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous Bβ-chain C-terminal 12 amino acid elongation variant, BβX462W (Kyoto VI), showed dysfibrinogenemia.
Okumura N; Terasawa F; Takezawa Y; Hirota-Kawadobora M; Inaba T; Fujita N; Saito M; Sugano M; Honda T
Blood Coagul Fibrinolysis; 2012 Jan; 23(1):87-90. PubMed ID: 22001526
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE
Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation.
de Raucourt E; de Mazancourt P; Maghzal GJ; Brennan SO; Mosesson MW
Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237
[TBL] [Abstract][Full Text] [Related]
19. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G
Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]